A Phase 1/2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit ofSAR444245 (THOR- 707) combined with cemiplimab for the treatment of participants with advancedunresectable or metastatic skin cancers

  • Domingo-Musibay, Evidio (PI)

Project: Research project

Project Details

Description

A Phase 1/2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit of SAR444245 (THOR- 707) combined with cemiplimab for the treatment of participants with advanced unresectable or metastatic skin cancers
StatusActive
Effective start/end date8/5/218/31/26

Funding

  • SANOFI-AVENTIS US

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.